533 Engineering Cancer

Tuesday, November 17, 2020: 8:00 AM - 9:00 AM
Chemical Engineers in Medicine (TF) (PreRecorded+)

Description:
This session highlights the contributions of chemical engineers changing the future of cancer diagnosis and treatment. This session explores exosomes, metastasis, development of drug resistance, evasion of the immune response, the impact of mass transport on tumor progression, dormancy, and recurrence and treatments for cancer including immunotherapy.

Sponsor:
Chemical Engineers in Medicine
Chair:
Young Jik Kwon Email: kwonyj@uci.edu
Co-Chair:
Thomas Zangle Email: tzangle@chemeng.utah.edu


(533a) Synergistic Cancer Gene Therapy Using Multi-Modal Gene Carriers in Combination with Chemotherapy
Margaret Lugin, Jee Young Chung, Angela Fleischman and Young Jik Kwon


(533b) Neutrophil Extracellular Traps and Extracellular Vesicles: Mediators of Metastasis in Breast Cancer?
Hunter Snoderly, Abby Ivey, Olivia Miller, Brian Boone and Margaret Bennewitz




(533d) Palmitate Induced Desmoplakin Loss and Enhanced Migration of Breast Cancer Cell Mediated By the IRE1α-XBP1-ZEB1 Pathway
Kevin Chen, Aritro Nath, Amrita Oak, R. Chauncey Splichal, Sean Foster, S. Patrick Walton and Christina Chan



(533g) Tumor Acidic Microenvironment Impairs Cancer Cell Migration
Se Jong Lee, Inês Godet, Elodie Henriet, Andrew Ewald, Daniele Gilkes and Konstantinos Konstantopoulos




See more of this Group/Topical: Topical Conference: Chemical Engineers in Medicine